Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 1365 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Genital infections with sodium glucose cotransporter-2 inhibitors: Occurrence and management in patients with type 2 diabetes mellitus

Unnikrishnan A G, Kalra Sanjay, Purandare Vedavati, Vasnawala Hardik

Year : 2018| Volume: 22| Issue : 6 | Page no: 837-842

   This article has been cited by
1 Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k)
Alex Farr,Isaak Effendy,Brigitte Frey Tirri,Herbert Hof,Peter Mayser,Ljubomir Petricevic,Markus Ruhnke,Martin Schaller,Axel P. A. Schaefer,Valentina Sustr,Birgit Willinger,Werner Mendling
Mycoses. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry Number 015/072, September 2020)
Alex Farr,Isaak Effendy,Brigitte Frey Tirri,Herbert Hof,Peter Mayser,Ljubomir Petricevic,Markus Ruhnke,Martin Schaller,Axel P. A. Schäfer,Birgit Willinger,Werner Mendling
Geburtshilfe und Frauenheilkunde. 2021; 81(04): 398
[Pubmed]  [Google Scholar] [DOI]
3 Recurrent and complicated urinary tract infection in type 2 diabetes: Case series
RahulR Kotalwar,GaurishM Karande,VedavatiB Purandare,HrishikeshS Deshmukh,AshootoshM Pakale,AmbikaGopalakrishnan Unnikrishnan
Journal of Diabetology. 2021; 12(2): 228
[Pubmed]  [Google Scholar] [DOI]
4 SGLT2 inhibitors and kidneys: mechanisms and main effects in diabetes mellitus patients
Vladimir V Salukhov,Yurii Sh. Khalimov,Sergey B. Shustov,Sergey I. Popov
Diabetes mellitus. 2021; 23(5): 475
[Pubmed]  [Google Scholar] [DOI]
5 Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CV
Matthew J. Budoff,Timothy M. E. Davis,Alexandra G. Palmer,Robert Frederich,David E. Lawrence,Jie Liu,Ira Gantz,Giuseppe Derosa
Diabetes Therapy. 2021;
[Pubmed]  [Google Scholar] [DOI]
6 Fixed-dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta-analysis
Niki Katsiki,Richard Ofori-Asenso,Ele Ferrannini,Mohsen Mazidi
Diabetes, Obesity and Metabolism. 2020;
[Pubmed]  [Google Scholar] [DOI]
7 Use of SGLT2 inhibitors during Ramadan: An expert panel statement
Mohamed Hassanein,Alaaeldeen Bashier,Hoosen Randeree,Megahed Abouelmagd,Waleed AlBaker,Bachar Afandi,Omar Abu Hijleh,Inass Shaltout,Magdy EI-Sharkawy,Selcuk Dagdelen,Samir Assaad Khalil
Diabetes Research and Clinical Practice. 2020; 169: 108465
[Pubmed]  [Google Scholar] [DOI]
8 Efficacy and tolerability of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A systematic review and network meta-analysis
Humaira Hussein,Francesco Zaccardi,Kamlesh Khunti,Melanie J. Davies,Emily Patsko,Nafeesa N. Dhalwani,David E. Kloecker,Ekaterini Ioannidou,Laura J. Gray
Diabetes, Obesity and Metabolism. 2020; 22(7): 1035
[Pubmed]  [Google Scholar] [DOI]
9 The association of sodium-glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews
Ryan Pelletier,Kelvin Ng,Wajd Alkabbani,Youssef Labib,Nicolas Mourad,John-Michael Gamble
Endocrinology, Diabetes & Metabolism. 2020;
[Pubmed]  [Google Scholar] [DOI]
10 Vulvovaginal Candidosis: Current Concepts, Challenges and Perspectives
Valentina Sustr,Philipp Foessleitner,Herbert Kiss,Alex Farr
Journal of Fungi. 2020; 6(4): 267
[Pubmed]  [Google Scholar] [DOI]
11 Infections and diabetes: Risks and mitigation with reference to India
Ranjit Unnikrishnan,Anoop Misra
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;
[Pubmed]  [Google Scholar] [DOI]


Read this article